XLO vs. XLF

In the year-to-date period, XLO achieves a 12.04% return, which is significantly higher than XLF's 5.82% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Xilio Therapeutics, Inc. (XLO) and Financial Select Sector SPDR Fund (XLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XLO Sharpe Ratio is 0.09, which is lower than the XLF Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of XLO and XLF, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

XLO has not paid dividends to shareholders, while XLF's dividend yield for the trailing twelve months is around 1.40%.

The maximum XLO drawdown since its inception was -98.01%, which is greater than XLF's maximum drawdown of -82.43%. Use the drawdown chart below to compare losses from any high point for XLO and XLF.

Xilio Therapeutics, Inc. (XLO) has a higher volatility of 59.80% compared to Financial Select Sector SPDR Fund (XLF) at 4.42%. This indicates that XLO's price experiences larger fluctuations and is considered to be riskier than XLF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.